Bone Biologics Corp BBLG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BBLG is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.52
- Day Range
- $1.51–1.61
- 52-Week Range
- $1.46–72.00
- Bid/Ask
- $1.56 / $1.61
- Market Cap
- $1.35 Mil
- Volume/Avg
- 28,507 / 84,172
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 2
- Website
- https://www.bonebiologics.com
Valuation
|
Metric
|
BBLG
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.28 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BBLG
|
|---|---|
Quick Ratio | 4.04 |
Current Ratio | 4.50 |
Interest Coverage | — |
Quick Ratio
BBLG
Profitability
|
Metric
|
BBLG
|
|---|---|
Return on Assets (Normalized) | −146.66% |
Return on Equity (Normalized) | −219.63% |
Return on Invested Capital (Normalized) | −219.68% |
Return on Assets
BBLG
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Bvknphzct | Stqkvv | $185.4 Bil | |
SYK
| Stryker Corp | Nykgbjymvd | Drzl | $127.7 Bil | |
BSX
| Boston Scientific Corp | Qkwwgqmzb | Pszvv | $107.6 Bil | |
MDT
| Medtronic PLC | Clnhgdd | Hyjyg | $105.9 Bil | |
DXCM
| DexCom Inc | Qynbsnnlq | Krqw | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Zhvkhvsrf | Nhhdp | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Kncmsvpfl | Dsmqd | $24.6 Bil | |
ALGN
| Align Technology Inc | Hvgkrbj | Ktbjm | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Yhjytwbhx | Wqmcb | $18.7 Bil | |
PODD
| Insulet Corp | Bjzwprwbs | Ffrzdv | $11.6 Bil |